Publication | Closed Access

The acute antiparkinsonian and antidyskinetic effect of AFQ056, a novel metabotropic glutamate receptor type 5 antagonist, in l-Dopa-treated parkinsonian monkeys

NeurophysiologyMedicineNeurotransmitterNeuropharmacologyNeuroprotectionNeuroscienceNeurologyPharmacotherapyL-dopa-treated Parkinsonian MonkeysAntidyskinetic EffectPharmacologyDopamineSocial Sciences